Lifecore Biomedical Inc (LFCR)

May 29, 2025, 10:05 AM EDT - 1 day ago

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 27, 2025, 10:00 AM EDT - 3 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect

May 27, 2025, 7:00 AM EDT - 3 days ago

Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer

May 25, 2025, 10:00 AM EDT - 5 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation

May 22, 2025, 10:00 AM EDT - 8 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation

May 19, 2025, 9:35 AM EDT - 11 days ago

Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings

BUR CLBT KKR PAR

May 18, 2025, 10:00 AM EDT - 12 days ago

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 15, 2025, 10:00 AM EDT - 15 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation

May 13, 2025, 10:00 AM EDT - 17 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation

May 11, 2025, 10:00 AM EDT - 19 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out

May 8, 2025, 10:00 AM EDT - 22 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out

May 6, 2025, 10:00 AM EDT - 24 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation

May 4, 2025, 10:00 AM EDT - 26 days ago

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 1, 2025, 10:00 AM EDT - 4 weeks ago

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation

Apr 29, 2025, 10:00 AM EDT - 4 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect

Apr 24, 2025, 11:30 AM EDT - 5 weeks ago

Laughing Water Capital Top 5 Investments (Q1 2025)

ARR NN PAR PLYA

Apr 22, 2025, 7:00 AM EDT - 5 weeks ago

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference

Apr 16, 2025, 4:05 PM EDT - 6 weeks ago

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 14, 2025, 7:00 AM EDT - 6 weeks ago

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer

Apr 6, 2025, 10:00 AM EDT - 7 weeks ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect

Apr 3, 2025, 7:43 PM EDT - 2 months ago

Lifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call Transcript

Apr 3, 2025, 4:05 PM EDT - 2 months ago

Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update

Apr 3, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out

Mar 27, 2025, 4:05 PM EDT - 2 months ago

Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025

Mar 17, 2025, 7:00 AM EDT - 2 months ago

Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome

Feb 26, 2025, 4:05 PM EST - 3 months ago

Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences

Feb 3, 2025, 7:00 AM EST - 4 months ago

Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference

Jan 17, 2025, 5:24 PM EST - 4 months ago

Lifecore Biomedical Announces Special Stockholder Meeting

Jan 7, 2025, 9:00 AM EST - 5 months ago

Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million

Jan 6, 2025, 4:05 PM EST - 5 months ago

Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 6:19 PM EST - 5 months ago

Lifecore Biomedical, Inc. (LFCR) Q2 2025 Earnings Call Transcript

Jan 2, 2025, 4:05 PM EST - 5 months ago

Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update

Dec 19, 2024, 4:05 PM EST - 5 months ago

Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025

Dec 19, 2024, 7:00 AM EST - 5 months ago

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment

Dec 1, 2024, 10:40 AM EST - 6 months ago

Lifecore Biomedical: An Interesting CDMO Pure Play

Nov 26, 2024, 4:05 PM EST - 6 months ago

Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO

Nov 21, 2024, 4:17 PM EST - 6 months ago

Lifecore Biomedical Hosts Virtual Investor Day

Nov 12, 2024, 4:05 PM EST - 7 months ago

Lifecore Biomedical to Present at Stephens Annual Investment Conference

Nov 7, 2024, 7:00 AM EST - 7 months ago

Lifecore Biomedical to Host Virtual Investor Day Prior to Market Open on November 21, 2024

Nov 4, 2024, 7:00 AM EST - 7 months ago

Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations

Oct 11, 2024, 9:44 AM EDT - 8 months ago

Johnson Fistel LLP Investigates Lifecore Biomedical, Inc's Directors and Officers for Breach of Fiduciary Duties and Encourages Long Term Shareholders to Reach Out for Their Options

Oct 4, 2024, 10:59 AM EDT - 8 months ago

Lifecore Biomedical, Inc. (LFCR) Q1 2025 Earnings Call Transcript

Oct 4, 2024, 7:30 AM EDT - 8 months ago

Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update

Oct 4, 2024, 7:20 AM EDT - 8 months ago

Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock

Oct 3, 2024, 4:05 PM EDT - 8 months ago

Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024

Oct 1, 2024, 7:00 AM EDT - 8 months ago

Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology

Sep 27, 2024, 11:00 AM EDT - 8 months ago

Lifecore Biomedical, Inc. Is Being Sued For Violating Securities Laws And Affected Shareholders Are Invited To Reach Out To The Schall Law Firm

Sep 27, 2024, 10:32 AM EDT - 8 months ago

FINAL DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore